Clinical trial
Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease
NCT02656017 is registered in ClinicalTrials.gov with Kyongtae Ty Bae, M.D., Ph.D. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease
- Lead sponsor
- Kyongtae Ty Bae, M.D., Ph.D.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 27, 2016
- Completion date
- December 7, 2020
- Enrollment
- 97 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.